Physician

Israel Zighelboim, MD

According to 2025 Medicare claims, Israel Zighelboim, MD (NPI: 1619907516) practices gynecologist/oncologist in the Allentown-Bethlehem-Easton, PA-NJ market, with the plurality of this provider's patient population coming from Lehigh, PA. This provider's primary affiliated billing organization is ST. LUKE'S PHYSICIAN GROUP, INC. (NPI: 1790793149; TIN: 232380812) and primary practice location at 18104-9263. Zighelboim is affiliated with the St. Luke's Medicare ACO (ACO ID: A3560), participating under the MSSP model.

Zighelboim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 171 traditional Medicare patients, billed 556 HCPCS/CPT codes, and received $62,034 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 309 prescription claims across 138 beneficiaries totaling $99,537 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 12 claims. Open Payments data shows 3 records totaling $347. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $16,766 and ending at $99,537. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,221 to $7,569.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	175	500	$78,611
2016	175	505	$75,578
2017	188	502	$76,306
2018	199	586	$63,236
2019	229	574	$69,684
2020	209	576	$60,587
2021	202	476	$65,641
2022	171	430	$59,958
2023	161	410	$64,985
2024	171	556	$62,034

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	67	148	$16,766
2016	60	126	$13,423
2017	66	112	$5,569
2018	39	69	$8,931
2019	50	68	$3,185
2020	53	98	$4,770
2021	39	102	$4,968
2022	37	94	$3,955
2023	39	62	$5,035
2024	138	309	$99,537

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	11	$552
2020	N/R	13	$668
2021	N/R	N/R	N/R
2022	N/R	12	$256
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	26	63	$142
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	68	94	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	61	92	$65
99459	Pelvic exam	41	44	$17
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	53	101	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	11	478	$8,656
Anastrozole	Anastrozole	165	14,859	$4,062
Exemestane	Exemestane	15	1,290	$3,665
Letrozole	Letrozole	20	1,800	$421

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$347	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Israel Zighelboim, MD?

Tedicare shows public-source Medicare data for Israel Zighelboim, MD (NPI 1619907516), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Israel Zighelboim, MD have ACO affiliation data?

Israel Zighelboim, MD is shown with ACO affiliation data for St. Luke's Medicare ACO (MSSP, ACO ID A3560).

What billing organization is linked to Israel Zighelboim, MD?

Israel Zighelboim, MD is linked to ST. LUKE'S PHYSICIAN GROUP, INC. (billing NPI 1790793149) in the available physician profile data.

Does Israel Zighelboim, MD have Open Payments data?

Israel Zighelboim, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.